Elevance Health stock pre-market at EUR 381.65: October 21 results scheduled
Published on 10/16/2026 at 08:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSDates and operating scale
- Elevance Health is scheduled to release third-quarter 2026 results on October 21, 2026.
- Elevance Health stock is at EUR 381.65 pre-market at 8:15 a.m. CEST at Lang & Schwarz on October 16, 2026.
- Elevance Health says its companies serve approximately 104 million consumers.
Elevance Health stock is at EUR 381.65 pre-market at Lang & Schwarz at 8:15 a.m. CEST on October 16, 2026. The displayed bid is EUR 378.90 and the ask is EUR 384.40. The price is reported separately from the company’s scheduled results event.
What matters today
Elevance Health is scheduled to release its third-quarter 2026 financial results on October 21, 2026 at 6:00 a.m. Eastern Daylight Time, followed by a management conference call at 8:30 a.m. EDT, according to the company’s investor-relations release. The company also states that its companies serve approximately 104 million consumers across medical, pharmacy, behavioral, clinical, home health and complex-care solutions.
Elevance Health is a health benefits and services company serving consumers, families and communities across the healthcare journey. Its investor-relations release says management will discuss the third-quarter results and outlook during the October 21 conference call.
Pre-market indication
The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Elevance Health stock.
Market context: Market report S&P 500.
